5LBA First efficacy findings from a randomized phase III trial of capecitabine + oxaliplatin vs. bolus 5-FU/LV for stage III colon cancer (NO16968/XELOXA study)

✍ Scribed by D. Haller; J. Tabernero; J. Maroun; F. de Braud; T. Price; E. Van Cutsem; M. Hill; F. Gilberg; K. Rittweger; H. Schmoll

• Book ID: 119600775
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 51 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(09)72033-6